quinazolines has been researched along with cardiovascular agents in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhargava, KP; Dubey, M; Kishor, K; Shanker, K; Sinha, JN; Verma, VK | 1 |
| Miyamoto, Y; Nakasone, J; Noguchi, K; Sakanashi, M | 1 |
| Evdokimov, EI; Stets, VR; Tishkin, VS | 1 |
| Carlier, J; D'Orio, V; el Allaf, D | 1 |
| Kaplan, HR; Smith, RD; Tessman, DK | 1 |
| Baird, JR; Blackburn, KJ; Cambridge, D; Constantine, JW; Ghaly, MS; Hayden, ML; McIlhenny, HM; Moore, PF; Olukotun, AY; Pullman, LG; Salsburg, DS; Saxton, CA; Shevde, S; Taylor, CR | 1 |
| Erol, K; Ertan, M; Kiliç, FS; Saraç, S; Yarim, M | 1 |
| Armstrong, P; Borer, J | 1 |
| HOHMANN, JR; JONES, JW | 1 |
| FRYER, RI; KELLER, O; METLESICS, W; SACH, G; STEIGER, N; STERNBACH, LH | 1 |
| Bartha, E; Halmosi, R; Hideg, K; Kálai, T; Kereskai, L; Lantos, J; Magyar, K; Plozer, E; Solti, I; Sumegi, B; Szabados, E; Toth, K | 1 |
2 review(s) available for quinazolines and cardiovascular agents
| Article | Year |
|---|---|
The new inotropic phosphodiesterase inhibitors.
Topics: Aminopyridines; Amrinone; Calcium; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Time Factors; Xanthines | 1984 |
Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure.
Topics: Animals; Asthma; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Ethanolamines; Heart Failure; Hemodynamics; Humans; Hypertension; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
1 trial(s) available for quinazolines and cardiovascular agents
| Article | Year |
|---|---|
Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure.
Topics: Animals; Asthma; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Ethanolamines; Heart Failure; Hemodynamics; Humans; Hypertension; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
9 other study(ies) available for quinazolines and cardiovascular agents
| Article | Year |
|---|---|
Synthesis of some newer piperazinoquinazolones as cardiovascular agents.
Topics: Animals; Blood Pressure; Cardiovascular Agents; Dogs; Female; Heart Rate; Hemodynamics; Male; Quinazolines | 1979 |
Pharmacological properties of 5-[(6,7,8-trimethoxy-4-quinazolinyl) amino]-1-pentanyl nitrate maleate in cardiovascular system.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Cardiovascular Agents; Cardiovascular System; Coronary Vessels; Dogs; Endothelium, Vascular; Female; Heart Rate; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitro Compounds; Nitroglycerin; Norepinephrine; Phenylephrine; Prazosin; Quinazolines; Rats; Rats, Inbred Strains; Regional Blood Flow; Vascular Resistance | 1991 |
[The efficacy of quinazopyrine, preparation E and riboxin in experimental myocardial infarct].
Topics: Animals; Cardiovascular Agents; Drug Evaluation, Preclinical; Heart; Inosine Diphosphate; Inosine Nucleotides; Isoproterenol; Male; Myocardial Infarction; Myocardium; Pituitary Hormones, Posterior; Quinazolines; Rats; Rats, Inbred Strains | 1989 |
Acute tolerance to prazosin in conscious hypertensive rats: involvement of the renin-angiotensin system.
Topics: Angiotensin II; Animals; Captopril; Cardiovascular Agents; Clonidine; Dose-Response Relationship, Drug; Drug Tolerance; Hydrochlorothiazide; Hypertension; Indomethacin; Male; Methyltyrosines; Prazosin; Propranolol; Quinazolines; Rats; Renin | 1981 |
4-aryl-6,6-dimethyl-1,2,3,4,5,6,7,8-octahydroquinazoline-2,5-diones: synthesis, chromatographic resolution and pharmacological activity.
Topics: Animals; Calcium Channel Blockers; Cardiotonic Agents; Cardiovascular Agents; Dimethyl Sulfoxide; Female; Heart Rate; Ileum; In Vitro Techniques; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Muscle Contraction; Muscle, Smooth; Myocardial Contraction; Quinazolines; Rats; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Stereoisomerism | 2001 |
Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adolescent; Adult; Advisory Committees; Anti-Infective Agents; Aza Compounds; Cardiovascular Agents; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Approval; Electrocardiography; Fluoroquinolones; Humans; Imidazoles; Impotence, Vasculogenic; Male; Middle Aged; Moxifloxacin; Phosphoric Diester Hydrolases; Piperazines; Prostatic Hyperplasia; Quinazolines; Quinolines; Risk Assessment; Sulfones; Triazines; United States; United States Food and Drug Administration; Vardenafil Dihydrochloride | 2003 |
Quaternary salts of 2,4,6-(dialkylaminoalkoxy)-1,3,5-triazines and 2,4-(dialkylaminoalkoxy)-quinazolines as curare agents.
Topics: Cardiovascular Agents; Curare; Muscle Relaxants, Central; Quinazolines; Salts; Triazines | 1954 |
QUINAZOLINES AND 1,4-BENZODIAZEPINES. X. NITRO-SUBSTITUTED 5-PHENYL-1,4-BENZODIAZEPINE DERIVATIVES.
Topics: Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Cardiovascular Agents; Chemistry, Pharmaceutical; Heterocyclic Compounds; Hypnotics and Sedatives; Mice; Muscle Relaxants, Central; Pharmacology; Quinazolines; Research; Toxicology | 1963 |
PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Topics: Administration, Oral; Animals; Blood Pressure; Cardiovascular Agents; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Male; Myocardium; Natriuretic Peptide, Brain; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinase C; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Rats, Inbred SHR; Signal Transduction; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2009 |